J&J Shares Fall Premarket Despite Raised 2026 Earnings Guidance

Key Facts

1Johnson & Johnson shares declined in premarket trading even as the company raised its earnings guidance for 2026.

Johnson & Johnson shares declined in premarket trading after the company raised its earnings guidance for 2026. Seeking Alpha reported that the drop occurred despite the healthcare giant delivering third-quarter results that were broadly in line with expectations and increasing its full-year sales and adjusted earnings outlook.

JNJ closed at $263.73 on October 12, 2026, having reached a day high of $264.39 and a low of $260.37. The market reaction suggests a 'sell the news' dynamic or underlying concerns that offset the positive Q3 performance and the upward revision of financial guidance.